Top Analyst Reports for Eli Lilly, Marriott & Fortinet
View original at finance.yahoo.comTop Analyst Reports for Eli Lilly, Marriott & Fortinet Wednesday, February 11, 2026 The Zacks Research Daily presents the best research output of our analyst team…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
GSI Technology's Gemini-II processor demonstrated superior power efficiency in edge AI benchmarks
80% confidenceStiff competition from Cisco Systems and Check Point Software poses concerns for Fortinet
80% confidenceDolby continues to see strong engagement across its ecosystem of creators, distributors and device OEMs, but macroeconomic weakness and stiff competition remain a concern
80% confidenceDemand for Eli Lilly's GLP-1 drugs Mounjaro and Zepbound remains strong, making them the company's key top-line drivers
80% confidenceMarriott's luxury properties continued to outperform on the back of healthy demand and favorable rates
80% confidenceKewaunee Scientific's consistently strong backlog provides revenue visibility and resilience
80% confidenceThe Itiviti acquisition has boosted Broadridge's global technology and operations segment, but low liquidity is concerning
80% confidenceRising R&D costs, widening operating losses and reliance on early-stage government projects present notable execution challenges for GSI Technology
80% confidenceFor Q1 2026, Fortinet guided EPS of $0.59-$0.63 on revenue of $1.70-$1.76 billion
80% confidenceOld Dominion is benefiting from shareholder-friendly measures, but high capital expenditures are concerning
80% confidenceGSI Technology is well-funded to scale R&D and product rollout with $70.7 million in cash and no debt
80% confidenceRoku benefits from increased user engagement on The Roku Channel and the popularity of the Roku TV program
80% confidenceHexcel Corporation is likely to benefit from improving air traffic, yet labor shortage may impact operating results
80% confidenceFortinet is benefiting from strength in demand from large enterprise customers and growth in security subscriptions amid a slowdown in networking products
80% confidenceChallenging macroeconomic conditions and high debt levels are a concern for Marriott
80% confidenceGSI Technology is targeting high-growth sectors like drones and mobile robotics with AI chips optimized for low-latency and low-power environments
80% confidenceBILL Holdings is likely to gain from its diversified business model, expansions into the SMB ecosystem and the adoption of its AI-powered platform despite competition
80% confidenceFortinet's dominant 50%+ firewall market share and extensive innovation portfolio of 1,400 global patents, including 500 AI-related innovations are expected to remain key growth drivers
80% confidenceKewaunee Scientific's diversified exposure across life sciences, healthcare, education, and government markets reduces cyclicality
80% confidenceMarriott is benefiting from higher RevPAR, solid rooms growth and continued development momentum
80% confidenceDeclining sales of Trulicity, rising pricing pressure on some drugs and potential competition in the GLP-1 market are top-line headwinds for Eli Lilly
80% confidenceConagra has been facing pressure from soft volume trends and unfavorable shipment timing. Volume declined 3% in Q2 fiscal 2026, weighing on organic sales
80% confidenceFull-year 2026 guidance calls for EPS of $2.94-$3.00 on revenue of $7.50-$7.70 billion
80% confidenceAngioDynamics' NanoKnife traction and robust product portfolio fuel optimism, though macroeconomic uncertainty may temper near-term demand
80% confidenceMonolithic Power Systems will benefit from solid traction in the Automotive, Enterprise Data Storage and Computing segment
80% confidenceA projected increase in EOG's operating costs and soft crude prices are expected to impact the company's profit margins and cash flows in the near term
80% confidencePrincipal Financial is set to grow on solid retirement business in Latin America and Asia as well as group benefits and protection in the US
80% confidenceGoodyear Forward transformation initiative is expected to deliver significant benefits in 2026, but high debt-to-capital ratio remains a concern
80% confidenceRobust growth trends in the U.S. incretin market and positive uptake trends in new international markets led to strong sales growth in 2025, with the positive trend expected to continue in 2026
80% confidenceEli Lilly's other new drugs like Kisunla, Omvoh and Jaypirca are contributing to top-line growth
80% confidence
Cited in these Via News reports
- Automation Slashes 200,000 Work Hours at US Bank as Global Insurers Report Surging Book Values →
- Fairfax Raises C$650M as Global Insurers Refinance Debt Amid Sector Consolidation →
- Global AI Chip Shortage Reaches 3-4% as Memory Prices Surge, New Competitors Challenge Nvidia →
- Global Insurers Report 14% Book Value Growth as Firms Signal Earnings Peak Has Passed →
- Markel Spends $919M on State National as Global Insurers Deploy $35B+ in Strategic Capital →
- Nordic Insurer OP Pohjola Flags Profit Drop While Fairfax Raises C$650M for Global M&A Push →